1. Home
  2. RCKT vs PCT Comparison

RCKT vs PCT Comparison

Compare RCKT & PCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • PCT
  • Stock Information
  • Founded
  • RCKT 1999
  • PCT 2015
  • Country
  • RCKT United States
  • PCT United States
  • Employees
  • RCKT N/A
  • PCT N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • PCT Environmental Services
  • Sector
  • RCKT Health Care
  • PCT Utilities
  • Exchange
  • RCKT Nasdaq
  • PCT Nasdaq
  • Market Cap
  • RCKT 1.9B
  • PCT 2.4B
  • IPO Year
  • RCKT N/A
  • PCT N/A
  • Fundamental
  • Price
  • RCKT $17.19
  • PCT $12.59
  • Analyst Decision
  • RCKT Strong Buy
  • PCT Buy
  • Analyst Count
  • RCKT 9
  • PCT 6
  • Target Price
  • RCKT $53.22
  • PCT $7.70
  • AVG Volume (30 Days)
  • RCKT 619.5K
  • PCT 3.1M
  • Earning Date
  • RCKT 11-12-2024
  • PCT 11-07-2024
  • Dividend Yield
  • RCKT N/A
  • PCT N/A
  • EPS Growth
  • RCKT N/A
  • PCT N/A
  • EPS
  • RCKT N/A
  • PCT N/A
  • Revenue
  • RCKT N/A
  • PCT N/A
  • Revenue This Year
  • RCKT N/A
  • PCT N/A
  • Revenue Next Year
  • RCKT $382.35
  • PCT $549.70
  • P/E Ratio
  • RCKT N/A
  • PCT N/A
  • Revenue Growth
  • RCKT N/A
  • PCT N/A
  • 52 Week Low
  • RCKT $15.98
  • PCT $2.39
  • 52 Week High
  • RCKT $32.53
  • PCT $15.58
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 47.06
  • PCT 62.09
  • Support Level
  • RCKT $16.48
  • PCT $12.13
  • Resistance Level
  • RCKT $17.75
  • PCT $13.62
  • Average True Range (ATR)
  • RCKT 0.73
  • PCT 1.02
  • MACD
  • RCKT 0.02
  • PCT -0.06
  • Stochastic Oscillator
  • RCKT 38.63
  • PCT 47.50

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.

About PCT PureCycle Technologies Inc. Common stock

PureCycle Technologies Inc holds a license to commercialize the only patented solvent-based purification recycling technology, developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene (PP) into a virgin-like resin. The proprietary process removes color, odor, and other contaminants from recycled feedstock resulting in virgin-like polypropylene suitable for any PP market.

Share on Social Networks: